FilingSEC EDGAR8-K
Curanex Pharmaceuticals Faces Securities Class Action Lawsuits Related to IPO
· SEC accepted
StageLitigation
Filing content
The company announced it is defending against two putative securities class action lawsuits alleging material misstatements and omissions in its August 2025 IPO offering documents.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…